Accelerating time to reperfusion in acute myocardial infarction: Prehospital and emergency department strategies, systems of care, and pharmacologic interventions

Reviews in Cardiovascular Medicine

Volumn 7, Issue SUPPL. 4, 2006, Pages

  Ornato, Joseph P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Abciximab; Aspirin; Clopidogrel; Heparin; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ARGATROBAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; METOPROLOL; MORPHINE SULFATE; OXYGEN; PLACEBO; RETEPLASE; STREPTOKINASE; TENECTEPLASE;

ACUTE HEART INFARCTION; ADJUVANT THERAPY; AMBULANCE; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CURRICULUM; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DOSAGE SCHEDULE COMPARISON; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; ELECTROCARDIOGRAPHY; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICAL SERVICES EDUCATION; HEALTH CARE QUALITY; HEART BLOCK; HEART CATHETERIZATION; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HOSPITALIZATION COST; HUMAN; LOADING DRUG DOSE; MONOTHERAPY; PARAMEDICAL EDUCATION; PARAMEDICAL PERSONNEL; PATIENT CARE; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; ST SEGMENT ELEVATION; STAFF TRAINING; TEAMWORK; TREATMENT OUTCOME; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; BLOOD PLATELETS; CARDIOVASCULAR AGENTS; COMMUNITY HEALTH SERVICES; CRITICAL PATHWAYS; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FIBRINOLYTIC AGENTS; HEALTH SERVICES ACCESSIBILITY; HEPARIN; HUMANS; MYOCARDIAL INFARCTION; PATIENT CARE TEAM; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROGRAM DEVELOPMENT; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME; TRIAGE; UNITED STATES;

EID: 33846497302     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
2. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283:2941-2947.
3. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223-1225.
4. Garvey JL, MacLeod BA, Sopko G, Hand MM. Pre-hospital 12-lead electrocardiography programs: a call for implementation by emergency medical services systems providing advanced life support. National Heart Attack Alert Program (NHAAP) Coordinating Committee; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health. J Am Coll Cardiol. 2006;47:485-491.
5. Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005;111:761-767.
6. Faxon D, Lenfant C. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. Circulation. 2001;104: 1210-1211.
7. Jacobs AK, Antman EM, Ellrodt G, et al. Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation. 2006;113:2152-2163.
8. Moyer P, Feldman J, Levine J, et al. Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the Boston EMS experience. Crit Pathways Cardiol. 2004;3:53-61.
9. Henry TD, Atkins JM, Cunningham MS, et al. ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers - is it time for a national policy for the treatment of ST-segment elevation myocardial infarction? J Am Coll Cardiol. 2006;47:1339-1345.
10. Henry TD, Sharkey SW, Graham KJ, et al. Transfer for direct percutaneous coronary intervention for ST-elevation myocardial infarction: the Minneapolis Heart Institute Level 1 myocardial infarction program. Circulation. 2005;112:II-620.
11. Brainard AH, Raynovich W, Tandberg D, Bedrick EJ. The prehospital 12-lead electrocardiogram's effect on time to initiation of reperfusion therapy: a systematic review and metaanalysis of existing literature. Am J Emerg Med. 2005;23:351-356.
12. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993;270:1211-1216.
13. Kereiakes DJ, Weaver WD, Anderson JL, et al. Time delays in the diagnosis and treatment of acute myocardial infarction - a tale of eight cities: report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J. 1990;120:773-780.
14. Williams D, with Fitch and Associates. 2004 JEMS 200-city survey. J Emerg Med Serv. 2005;30:42-60.
15. Jacoby J, Axelband J, Patterson J, et al. Cardiac cath lab activation by the emergency physician without prior consultation decreases door-to-balloon time. J Invasive Cardiol. 2005;17:154-155.
16. Lipton JA, Broce M, Lucas D, et al. Comprehensive hospital care improvement strategies reduce time to treatment in ST-elevation acute myocardial infarction. Crit Pathways Cardiol. 2006;5:29-33.
17. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:e82-292.
18. Brown AL, Mann NC, Daya M, et al. Demographic, belief, and situational factors influencing the decision to utilize emergency medical services among chest pain patients. Rapid Early Action for Coronary Treatment (REACT) Study. Circulation. 2000;102:173-178.
19. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2. Lancet. 1988;2:349-360.
20. Freimark D, Matetzky S, Leor J, et al. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol. 2002;89:381-385.
21. Zijlstra F, Ernst N, de Boer MJ, et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol. 2002; 39:1733-1737.
22. Borden WB, Faxon DP. Facilitated percutaneous coronary intervention. J Am Coll Cardiol. 2006; 48:1120-1128.
23. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004;364:1045-1053.
24. Le May MR, Wells GA, Labinaz M, et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol. 2005;46:417-424.
25. Ellis SG, Armstrong P, Betriu A, et al. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. Am Heart J. 2004;147:E16.
26. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet. 2006;367:579-588.
27. van't Hof AW, Ernst N, de Boer MJ, et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. Eur Heart J. 2004;25:837-846.
28. Lee DP, Herity NA, Hiatt BL, et al. Adjunctive platelet glycoprotein IIb/ IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial. Circulation. 2003;107:1497-1501.
29. Mesquita Gabriel H, Oliveira JA, da Silva PC, et al. Early administration of abciximab bolus in the emergency room improves microperfusion after primary percutaneous coronary intervention, as assessed by TIMI frame count: results of the (ERAMI) trial. Eur Heart J. 2003;24(suppl): 543 (abstr).
30. Arntz HR, Schroeder J, Pels K, Schwimmbeck P, et al. Prehospital versus periprocedural administration of abciximab in STEMI: early and late results from the randomised REOMOBILE study. Eur Heart J. 2003;24(suppl):268 (abstr).
31. Zorman S, Zorman D, Noc M. Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol. 2002;90:533-536.
32. Cutlip DE, Ricciardi MJ, Ling FS, et al. Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. Am J Cardiol. 2003;92:977-980.
33. Gyongyosi M, Domanovits H, Benzer W, et al. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion-results of the Austrian multicentre randomized ReoPro-BRIDGING Study. Eur Heart J. 2004;25:2125-2133.
34. Zeymer U, Zahn R, Schiele R, et al. Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial. Eur Heart J. 2005;26:1971-1977.
35. Bellandi F, Maioli M, Leoncini M, et al. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. Int J Cardiol. 2005; published online May 31. DOI: doi:10.1016/j.ijcard.2005. 04.025
36. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005;293:1759-1765.
37. Godicke J, Flather M, Noc M, et al. Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies. Am Heart J. 2005;150:1015.
38. Bellandi F, Maioli M, Leoncini M, et al. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. Int J Cardiol. 2006;108:36-42.
39. Leoncini M, Toso A, Maioli M, et al. Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach: results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study. Am Heart J. 2005;150:401.
40. Maioli M, Gallopin M, Leoncini M, et al. Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours. Catheter Cardiovasc Interv. 2005;65:484-491.
41. Antman E, Anbe D, Armstrong P. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2004;44(3):671-719.
42. Scirica BM, Sabatine MS, Morrow DA, et al. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction. The ECG CLARITY-TIMI 28 Study. J Am Coll Cardiol. 2006;48:37-42.
43. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1622-1632.